Genetic strategies for antibacterial drug discovery
- 1 June 2003
- journal article
- review article
- Published by Springer Nature in Nature Reviews Genetics
- Vol. 4 (6) , 442-456
- https://doi.org/10.1038/nrg1086
Abstract
The availability of genome sequences is revolutionizing the field of microbiology. Genetic methods are being modified to facilitate rapid analysis at a genome-wide level and are blossoming for human pathogens that were previously considered intractable. This revolution coincided with a growing concern about the emergence of microbial drug resistance, compelling the pharmaceutical industry to search for new antimicrobial agents. The availability of the new technologies, combined with many genetic strategies, has changed the way that researchers approach antibacterial drug discovery.Keywords
This publication has 163 references indexed in Scilit:
- Role of Mobile DNA in the Evolution of Vancomycin-Resistant Enterococcus faecalisScience, 2003
- Complete Genome Sequence of a Virulent Isolate of Streptococcus pneumoniaeScience, 2001
- Improved microbial gene identification with GLIMMERNucleic Acids Research, 1999
- Drug target validation and identification of secondary drug target effects using DNA microarraysNature Medicine, 1998
- Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequenceNature, 1998
- Gapped BLAST and PSI-BLAST: a new generation of protein database search programsNucleic Acids Research, 1997
- Prediction of complete gene structures in human genomic DNAJournal of Molecular Biology, 1997
- Life with 6000 GenesScience, 1996
- A double counter-selection system for the study of null alleles of essential genes in escherichia coliGene, 1995
- Molecular Properties of Two Mutant Species of the Elongation Factor TuEuropean Journal of Biochemistry, 1981